Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Combined tofacitinib citrate and 308-nm excimer laser treatment for vitiligo: a pilot study

This study confirmed a rapid and effective treatment of vitiligo was achieved through a combination of TC and 308-nm EL. No serious adverse reactions were reported, and therefore this could potentially offer an optimal treatment plan for patients with vitiligo.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors compared oral tofacitinib citrate plus 308-nm excimer laser with methylprednisolone in 63 patients with progressive vitiligo over 24 weeks. They report that combined tofacitinib and laser was faster-acting than the other arms, with no serious adverse reactions. The study is a pilot, so the authors describe the approach as potentially optimal rather than established.

Participants
63
Who or what was studied
Patients with progressive vitiligo and a Vitiligo Disease Activity Score of 4, enrolled January 2022 to January 2024
Wavelengths
308 nm
Limits stated in the abstract
The abstract describes this as a pilot study and does not report a control arm receiving no treatment or long-term follow-up beyond 24 weeks.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser, Pilot study. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies